# FDA 483 - Lifesouth Community Blood Centers - Montgomery Region - April 14, 2025

Source: https://www.keypedia.com/records/483/lifesouth-community-blood-centers-montgomery-region/0c870d1b-7d82-4b88-806b-dc3379e67213

> FDA 483 for Lifesouth Community Blood Centers - Montgomery Region on April 14, 2025. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Lifesouth Community Blood Centers - Montgomery Region
- Inspection Date: 2025-04-14
- Product Type: biologics
- Office Name: New Orleans District Office
- Summary: Lifesouth Community Blood Centers - Montgomery Region was inspected and cited for significant deficiencies in phlebotomy site preparation, investigation of ABO blood grouping discrepancies, and quality control procedures for supplies and reagents. The observations indicate a lack of adherence to manufacturer instructions, internal SOPs, and federal regulations, potentially impacting the sterility of blood products and accuracy of blood typing.

## Related Officers

- [Fabian N. Chaparro-rodriguez](https://www.keypedia.com/people/fabian-n-chaparro-rodriguez/f14fd931-0830-4a84-a287-2dd85e40195d)

Company: https://www.keypedia.com/companies/lifesouth-community-blood-centers-montgomery-region/88211c9f-fd6f-4a37-9818-f03d67b2e2bb

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea